Functionalized Coacervates for Cancer Therapy: Advances and Prospects in Phase‐Separation–Based Intelligent Drug Delivery
Small · 2026-08 · 22 (47)
DOI: 10.1002/smll.74466 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, online erschienen am 28.07.2026. Verfasst von Pu-Ge Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical En…. Hauptthemen laut MEDLINE: Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Frontier Technologies R&D Program of Jiangsu.
Abstract (Originalsprache)
Functionalized coacervates, a type of nanomaterial inspired by biomolecular condensation, have emerged as an important research direction in biomedicine, particularly in cancer therapy. These membraneless structures formed by liquid–liquid phase separation (LLPS) self‐assembly have high drug‐loading capacity, favorable biocompatibility, and tunable responsiveness to tumor microenvironment (TME) cues. This programmability enables targeted delivery and controlled release. This review summarizes the latest progress in the design and therapeutic application of functionalized coacervates in cancer therapy. We first introduce the construction strategies, including basic driving forces, material platforms, and advanced architectures. Then, we explain the mechanisms that enhance therapeutic efficacy and reduce toxicity, including enhanced loading and stability, improved pharmacokinetics and tumor accumulation, and enhanced intracellular delivery that can overcome multidrug resistance (MDR). We also discuss spatiotemporal release triggered by TME cues, such as acidity, redox, or enzymatic activity. Next, we highlight applications in chemotherapy, nucleic acid delivery, cancer immunotherapy, multimodal combination therapy, and emerging directions. Finally, we discuss translational challenges and outline future research directions. We aim to provide a coherent framework for researchers and to facilitate the development and clinical translation of coacervate‐based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, People's Republic of China.
ORCID-Profile: Yu Zhang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Frontier Technologies R&D Program of Jiangsu
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Yu, P. G., Li, Q. Q., Wang, J. M., Wu, H., Ma, M., & Zhang, Y. (2026). Functionalized Coacervates for Cancer Therapy: Advances and Prospects in Phase‐Separation–Based Intelligent Drug Delivery. Small, 22(47). https://doi.org/10.1002/smll.74466
Vancouver
Yu PG, Li QQ, Wang JM, Wu H, Ma M, Zhang Y. Functionalized Coacervates for Cancer Therapy: Advances and Prospects in Phase‐Separation–Based Intelligent Drug Delivery. Small. 2026;22(47). doi:10.1002/smll.74466
BibTeX
@article{Yu2026,
author = {Yu, Pu-Ge and Li, Qian-Qian and Wang, Jia-Ming and Wu, Haoan and Ma, Ming and Zhang, Yu},
title = {Functionalized Coacervates for Cancer Therapy: Advances and Prospects in Phase‐Separation–Based Intelligent Drug Delivery},
journal = {Small},
year = {2026},
volume = {22},
number = {47},
doi = {10.1002/smll.74466}
}
EUVIMED